Health Care/Hospital

Transcenta Holding Secures $100 Million Series B Plus Financing

HONG KONG and SUZHOU and HANGZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D, and manufacturing of antibody-based therapeutics, announces today that it has sealed a 100 millio...

2020-01-08 21:00 1546

Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies

SUZHOU, China and SHANGHAI, Jan. 7, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced the initiation of an investigational study of GC027, the first product candidate developed usingTruUCAR™ to treat relapsed or refr...

2020-01-07 22:00 1071

Beta Lifescience Announces the Online Availability of Quality Immune Checkpoint Proteins for Scientific Discoveries

FIREFILED, N.J., Jan. 7, 2020 /PRNewswire/ -- Beta Lifescience, a world leading biotech company based in NJ, USA, announces that scientists in the field of cancer immunotherapy, immune checkpoint, targeted therapy, etc. now have access to the quality immune checkpoint protein products through the...

2020-01-07 21:10 854

Transcenta to Present at the 38th Annual J.P. Morgan Healthcare Conference

HONG KONG, SUZHOU, China and HANGZHOU, China, Jan. 6, 2020 /PRNewswire/ -- Transcenta Holding (Transcenta) today announced that Co-founder & CEO Dr. Xueming Qian will present at the 38th Annual J.P. Morgan Healthcare Conference onWednesday, January 15, 2020, at 14:30 PST in Golden Gate room at Wes...

2020-01-07 00:00 1328

Presagen and Life Whisperer Announce Call-out for a Global IVF Clinic Collaboration at CES 2020

SAN MATEO, Calif. and ADELAIDE, Australia, Jan. 6, 2020 /PRNewswire/ -- Life Whisperer, the fertility arm of AI healthcare company Presagen, which operates out ofSan Mateo and South Australia, recently presented the results of groundbreaking research at the prestigious American Society for Reprod...

2020-01-06 23:47 1450

Happiness Biotech Announces the Opening of its First Experience Store in Hainan, China, introducing the Company's 31st Experience Store

NANPING, China, Jan. 6, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today the opening of its first experience store inHainan, China, which is the Company's 31st experience ...

2020-01-06 21:00 9481

Lianluo Smart Announces Receipt of Nasdaq Non-compliance of Stockholders' Equity Notification

BEIJING, Jan. 6, 2020 /PRNewswire/ -- Lianluo Smart Limited (the "Company") announced today that it has received a letter from the staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") onJanuary 2, 2020, providing notification that the Company no longer complies with the minimum of$2.5 mi...

2020-01-06 19:00 9920

CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs

SHANGHAI, Jan 6, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, today announced appointment ofYong Fan, MD, as Senior Vice President, Global Regulatory Affairs. Dr. Fan, will be responsible for CAR...

2020-01-06 18:00 4041

GPHL's international headquarters settle in Macao, first project during the fifth-term government of Macao SAR

GUANGZHOU, China, Jan. 6, 2020 /PRNewswire/ -- The beginning of 2020 witnessed key projects promoting the cooperation betweenGuangdong and Macao. On January 3 , Guangzhou Pharmaceutical Group (Macau) International Development Co., Ltd. (hereunder referred to as "the company") was established inMac...

2020-01-06 14:39 1374

Nunaps raises US$4.2M to develop patient-centered digital therapeutics platform for brain damage

SEOUL, South Korea, Jan. 5, 2020 /PRNewswire/ -- Nunaps, a South Korean digital therapeutics startup, has closed aKRW 5 billion (US$ 4.2 million) Series A round by Company K Partners, KTB Network, and K2 Investment Partners. The company plans to use the fresh capital to build digital therapeutics...

2020-01-06 12:54 1265

111 Inc to Attend the JP Morgan 2020 Healthcare Conference in San Francisco, January 14-15, 2020

SHANGHAI, Jan. 3, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will attend  the JP Morgan 2020 Healthcare Conference in San Francisco, CA, USA, January 14-15, 2020 and meet with ...

2020-01-04 08:00 6410
1 ... 278279280281282